Investing Profile

Daniel Wagner

Sr. Managing Director, Investments at Connecticut Innovations
ctinnovations.com/member/dani...Connecticut
Photo of Daniel Wagner, Managing Director at Connecticut Innovations
Your Intro Paths to Daniel Wagner

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Daniel is a member of
Connecticut Innovations Network
17 CONNECTIONS
Connecticut Innovations Network
17 CONNECTIONS
Connecticut Innovations Network
17 CONNECTIONS
University of Dayton Network
16 CONNECTIONS
University of Dayton Network
16 CONNECTIONS

Find Daniel Wagner on

cb
Current Investing Position
Connecticut Innovations Managing Director
Investment Range
$150K - $7.0M
Sweet Spot
$3.5M
Investments On Record
19
Current Fund Size
$4M

Daniel Wagner is on these Sector & Stage Rankings

Daniel Wagner's Investments On Record (9)

CompanyStageDateRound SizeTotal Raised
P2 Science
Series UnknownMay 2026$23M
Series CJan 2020$12M
Series AApr 2014$1M
SeedMay 2013$650K
SeedMar 2013$200K
$37M
Encapsulate
SeedJun 2024$2M
$2M
Co-investors: Sam Goldberger (Ambit Health Ventures), Eric Tan (Blackwood Healthcare Breakthroughs)
Biorez
SeedSep 2020$4M
Series CMar 2018$2M
Series UnknownJan 2014$5M
$11M
Co-investors: Elon Boms (Pritzker Vlock Capital Management)
Tangen Biosciences
Series AJun 2019$9M
$9M
New Haven Pharmaceuticals
Series BOct 2014$12M
Series AOct 2012$6M
$18M
Arvinas
Series ASep 2013$15M
$140M
Co-investors: Tim Shannon (Canaan Partners), Colleen Cuffaro (Canaan Partners), Kush Parmar (5am Ventures), Martin Alexander Gershon (Endeavor Venture Funds), Liam Ratcliffe (New Leaf Venture Partners), Stephen Squinto (J.P. Morgan Asset Management), Andrew Levin (RA Capital Management), Jakob Loven (Nextech Invest Ltd.)
Innovatient Solutions
Series AApr 2013$630K
Debt FinancingNov 2012$250K
Series AApr 2011$2M
$2.9M
Co-investors: Matthew Storeygard (Connecticut Innovations)
SAMI Health
Series UnknownOct 2012$750K
SeedFeb 2012$500K
$1.3M

Daniel Wagner's Experience

Board Member Tangen Biosciences, Inc.Present
Board Member BiorezPresent
Board Member AlloMek Therapeutics LLCPresent
Board Observer Azitra IncPresent
Sr. Managing Director, Investments Connecticut InnovationsPresent
Sr. Managing Director, Investments Connecticut InnovationsPresent
Investor Halda TherapeuticsPresent
Board Observer Simcha TherapeuticsPresent
Board Member ProteoWisePresent
Board Observer Artizan Biosciences, Inc.Present
Board Observer TastesNatural™, LLCPresent
Board Observer Tastes Natural, LLCPresent
Board Observer BEKHealthPresent
Board Observer Alphina TherapeuticsPresent
Board Observer CareSciencePresent
Board Observer Siduma TherapeuticsPresent
Board Observer RIGImmune Inc.Present
Board Observer RIGImmunePresent
Board Observer Manifest TechnologiesPresent
Board Member Intus BioPresent
Board Member Enrich Biosystems Inc.Present
Board Observer Revalia BioPresent
Board Member EncapsulatePresent
Investor Bexorg, Inc.Present
Consultant Connecticut InnovationsPresent

Daniel Wagner's Education

University of Dayton BS BS, Biology
University of Dayton BS Biology
Quinnipiac University MHS MHS, Biomedical Sciences
Quinnipiac University MHS Biomedical Sciences
Quinnipiac University Master of Business Administration - MBA Finance

Investors who invest with Daniel Wagner

Sign in with Google →

Scouts & Angels Affiliated With Daniel Wagner

Sign in with Google →